“…In a recent study, the CysLT 1 R has been associated with cytokine transduction signals for the up-regulation of eosinophilopoiesis by IL-13 and eotaxin in murine bone marrow (Queto et al, 2010). These data support early reports demonstrating the inhibitory action of CysLT 1 R antagonists on eosinophil activation and migration (Virchow et al, 2001;Fregonese et al, 2002;Suzuki et al, 2003;Ueda et al, 2003;Saito et al, 2004;Nagata et al, 2005), as well as on adhesion (Fregonese et al, 2002;Nagata et al, 2002;Kushiya et al, 2006;Meliton et al, 2007;Profita et al, 2008). There is considerable information available to demonstrate the ability of CysLTR antagonists to reduce airway eosinophilia and eosinophil cationic protein (ECP) in animals (Underwood et al, 1996;Ihaku et al, 1999) and in humans (Pizzichini et al, 1999;Obase et al, 2002;Steinke et al, 2003;Strauch et al, 2003;Laitinen et al, 2005;Kopriva et al, 2006).…”